Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis



Status:Archived
Conditions:Allergy, Ocular
Therapuetic Areas:Ophthalmology, Otolaryngology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:February 2011
End Date:May 2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Dose Ranging Study to Evaluate the Safety and Efficacy of Mapracorat Ophthalmic Formulation, in Subjects With Allergic Conjunctivitis Compared to Vehicle in a Conjunctival Allergen Challenge (CAC).


The objective of this study is to evaluate the dose response, and efficacy of Mapracorat
ophthalmic formulation compared to its vehicle for the prevention of symptoms and signs
associated with allergic conjunctivitis using a conjunctival allergen challenge (CAC) model.



We found this trial at
1
site
Bausch & Lomb
Rochester, New York 14609
?
mi
from
Rochester, NY
Click here to add this to my saved trials